Genetic Risks and Doctors’ Disclosure Obligations — Revisiting the Duty of Confidentiality
| Autor: | Aisling de Paor |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
ComputingMilieux_THECOMPUTINGPROFESSION
medicine.diagnostic_test Emerging technologies business.industry Health Policy Common law Internet privacy 06 humanities and the arts 0603 philosophy ethics and religion 03 medical and health sciences 0302 clinical medicine Duty of confidentiality medicine Confidentiality Health law 060301 applied ethics 030212 general & internal medicine Obligation business Law Duty of disclosure Genetic testing |
| Zdroj: | European Journal of Health Law. 25:365-388 |
| ISSN: | 1571-8093 0929-0273 |
| DOI: | 10.1163/15718093-12252373 |
| Popis: | With developments in the field of genetics, new technologies such as genetic testing are fast emerging. Although offering unparalleled opportunities, these developments raise many ethical, legal and other issues. One challenge relates to the duty of confidentiality and disclosure obligations on doctors. Considering the familial nature of genetic information, doctors will increasingly have access to predictive health information, about individuals and individuals’ relatives. This article examines whether disclosure obligations on doctors should be expanded to encompass an obligation to disclose genetic risk to family members, and whether the exceptions to the duty of confidentiality should recognise genetic risk as potential harm. With recognition of the competing rights, the article considers the implications of recent case law in the United Kingdom, indicating a willingness to extend the duty of disclosure. This article argues that there is a case to be made for expanding disclosure obligations on doctors in certain circumstances. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |